Global Immunology Market

Immunology Market Size, Share, Growth Analysis, By Drug Class(Monoclonal Antibody, Immunosuppressants, Fusion Proteins, and Others), By Disease Indication(Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2245 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 68 |Figures: 75

Immunology Market Insights

Global Immunology Market size was valued at USD 97.93 Billion in 2021 and is poised to grow from USD 106.25 Billion in 2022 to USD 204.07 Billion by 2030, at a CAGR of 8.5% during the forecast period (2023-2030).

The global immunology market is a dynamic and rapidly evolving sector within the healthcare and pharmaceutical industry. The purpose of the global immunology market is to address various immune-related disorders and diseases by developing innovative therapies and diagnostic tools. Immunology plays a crucial role in understanding the functioning of the immune system, identifying its dysregulation, and developing interventions to modulate or enhance immune responses. One of the driving factors in the immunology market is the increasing prevalence of immune-related disorders, including autoimmune diseases, cancer, allergies, and infectious diseases. These conditions pose significant healthcare challenges worldwide, driving the need for effective immunological interventions.

Additionally, advancements in biotechnology and molecular biology have led to the development of targeted immunotherapies, boosting the growth of the market. There are also several restraining factors that impact the global immunology market. High treatment costs, stringent regulatory requirements, and complex reimbursement systems pose challenges for the adoption of immunological therapies. Limited awareness and access to advanced immunotherapies in developing regions can also hinder market growth. The market faces various challenges, including the need for better understanding of disease mechanisms, identification of biomarkers for patient stratification, and the development of personalized immunotherapies. Additionally, the complexity of the immune system and its interactions with other physiological processes present scientific and technical challenges in developing effective immunological interventions. Despite the challenges, there are significant opportunities in the global immunology market.

The advancements in genomic and proteomic technologies, along with the growing understanding of immune system regulation, open avenues for the development of novel immunotherapies. Moreover, the rise of precision medicine and the integration of immunological approaches with other treatment modalities offer promising opportunities for targeted and personalized immunotherapeutic interventions. The global immunology market serves the purpose of addressing immune-related disorders by developing innovative therapies and diagnostic tools. While driving factors include the increasing prevalence of immune-related diseases and advancements in biotechnology, restraining factors such as high costs and complex regulations pose challenges. Overcoming these challenges and capitalizing on opportunities such as precision medicine can pave the way for significant advancements in the field of immunology.

Market Snapshot - 2024-2031

Global Market Size

USD 97.93 Billion

Largest Segment

Monoclonal Antibody

Fastest Growth

Monoclonal Antibody

Growth Rate

8.5% CAGR

Global Immunology Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Immunology Market Segmental Analysis

The global immunology market is segmented on the basis of drug class, disease indication, and region. By drug class, the market is segmented into monoclonal antibodies, immunosuppressants, fusion proteins, and others. By disease indication, the market is segmented into rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, inflammatory bowel disease, prophylaxis of organ rejection, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Analysis by Drug Class

The monoclonal antibody (mAb) segment emerged as the dominant sector within the global immunology market. This dominance can be attributed to the proven clinical effectiveness of recognized monoclonal antibodies such as rituximab and adalimumab in the treatment of autoimmune diseases, chronic conditions, and rare disorders. Furthermore, the segment benefits from a higher number of authorizations granted for mAbs to treat a wide range of conditions, which further supports its growth.

During the forecast period, the immunosuppressants segment is expected to experience a higher compound annual growth rate (CAGR). This rapid growth can be attributed to the significant focus on research and development (R&D) by leading market players, aiming to obtain increasing regulatory approvals for these drugs. Additionally, the growing adoption of immunosuppressants in developing nations, owing to their higher treatment efficacy, contributes to the segment's faster growth rate.

Analysis by Disease Indication

Rheumatoid Arthritis, the largest segment in the immunology market, holds a significant market share due to its high prevalence and the substantial impact it has on patients' quality of life. With approximately 1% of the global population affected by RA, the demand for effective treatments is substantial. The segment's attractiveness lies in the clinical efficiency of immunological therapies such as monoclonal antibodies, which have revolutionized the management of RA. Drugs like adalimumab and rituximab have demonstrated remarkable efficacy in reducing inflammation, relieving pain, and improving joint function in RA patients. These therapies have paved the way for disease remission and a better quality of life for millions of individuals worldwide.

The fastest growing segment in the global immunology market is Psoriatic Arthritis. PsA is a chronic inflammatory condition that affects individuals with psoriasis, a skin disorder characterized by red, scaly patches. The prevalence of PsA is rising, affecting approximately 20-30% of individuals with psoriasis. This segment's rapid growth is driven by the unmet medical needs of PsA patients and the increasing recognition of the disease's impact on both joints and skin. Moreover, advancements in understanding the underlying immune mechanisms involved in PsA have led to the development of novel immunological therapies specifically targeting this condition. These therapies, including biologics like ustekinumab and secukinumab, have demonstrated impressive clinical outcomes by effectively reducing joint inflammation and skin manifestations.

Global Immunology Market By Drug Class, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Immunology Market Regional Insights

North America holds a significant share in the global immunology market and dominates due to several factors. The region has a well-established healthcare infrastructure, a high prevalence of immune-related diseases, and a robust research and development sector. Additionally, North America boasts a strong presence of key market players and pharmaceutical companies focusing on immunological research and product development. The region's dominance is further supported by the favorable reimbursement policies and regulatory frameworks that facilitate the adoption of immunological therapies. With a strong emphasis on innovation and advanced healthcare services, North America continues to lead the immunology market.

Asia Pacific represents the fastest-growing segment in the global immunology market. The region's rapid growth can be attributed to multiple factors. First, the Asia Pacific has a large population base, including a significant proportion of individuals affected by immune-related diseases. This creates a substantial demand for immunological therapies and treatments. Second, increasing healthcare expenditure, rising disposable incomes, and improving healthcare infrastructure in countries like China, India, and Japan contribute to the growth of the market. Additionally, the region's focus on research and development, coupled with collaborations with international pharmaceutical companies, accelerates the development and adoption of immunological therapies.

Global Immunology Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Immunology Market Dynamics

Drivers

Advancements in Biotechnology

  • The rapid advancements in biotechnology have significantly contributed to the growth of the immunology market. The development of novel biologics and targeted therapies has revolutionized the treatment landscape for immune-related disorders. For example, in 2022, the FDA approved a new biologic called bimekizumab for the treatment of psoriasis and psoriatic arthritis. Bimekizumab demonstrated superior efficacy compared to existing treatments, highlighting the potential of biotechnology in driving innovation and improving patient outcomes.

Increasing Prevalence of Immune-related Diseases

  • The rising prevalence of immune-related diseases, such as autoimmune disorders and cancer, continues to drive the demand for immunological interventions. For instance, the increasing incidence of rheumatoid arthritis, a chronic autoimmune condition, has led to the development of targeted therapies such as Janus kinase (JAK) inhibitors. These inhibitors, such as tofacitinib and upadacitinib, gained significant traction in 2022 due to their efficacy in managing rheumatoid arthritis symptoms and improving patients' quality of life.

Restraints

High Treatment Costs

  • The high costs associated with immunological therapies pose a significant restraint on the market. The development and manufacturing of biologics and targeted therapies involve complex processes, leading to high production costs. These costs are often transferred to patients and healthcare systems, limiting access to these treatments, particularly in developing regions. The challenge of affordability continues to be a key restraint in achieving broader adoption of immunological interventions.

Stringent Regulatory Requirements

  • The immunology market is subject to stringent regulatory requirements, particularly for the approval and commercialization of novel therapies. The rigorous evaluation process, including extensive clinical trials and regulatory submissions, can lead to significant delays and increased costs for manufacturers. Adhering to these regulatory requirements can be a challenge, especially for smaller biotechnology companies, hampering the timely entry of innovative immunological products into the market.

Request Free Customization of this report to help us to meet your business objectives.

Immunology Market Competitive Landscape

The global immunology market is characterized by intense competition among key players striving to gain a significant market share. The market is witnessing the participation of both established pharmaceutical companies and emerging biotechnology firms, all vying to develop innovative immunological therapies and gain a competitive edge. companies in the immunology market focus on securing regulatory approvals for their products, adhering to stringent quality and safety standards. They also emphasize post-market surveillance and pharmacovigilance to ensure the continued efficacy and safety of their therapies.

Top Player’s Company Profiles

  • Johnson & Johnson (US)
  • Roche Holdings AG (Switzerland)
  • AbbVie Inc. (US)
  • Pfizer Inc. (US)
  • Novartis International AG (Switzerland)
  • Merck & Co., Inc. (US)
  • Bristol-Myers Squibb Company (US)
  • Amgen Inc. (US)
  • Eli Lilly and Company (US)
  • AstraZeneca PLC (UK)
  • Gilead Sciences, Inc. (US)
  • Sanofi (France)
  • Biogen Inc. (US)
  • Regeneron Pharmaceuticals, Inc. (US)
  • Celgene Corporation (US)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Boehringer Ingelheim International GmbH (Germany)
  • Janssen Pharmaceuticals (US)
  • UCB S.A. (Belgium)
  • Genentech, Inc. (US)

Recent Developments

  • In May 2023, Pfizer Inc. announced the approval of rituxizumab for the treatment of pemphigus vulgaris.
  • In June 2022, Eli Lilly and Company received the U.S. FDA approval for OLUMIANT as a first-in-disease systemic treatment for adults with severe alopecia areata (AA), an autoimmune disorder.
  • In March 2022, Pfizer Inc. acquired Arena Pharmaceuticals, a company that develops innovative potential therapies for the treatment of several immune-inflammatory diseases to strengthen its product portfolio.
  • In February 2022, UCB S.A. received the marketing authorization from Health Canada BIMZELX (bimekizumab injection) for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Immunology Key Market Trends

  • Personalized Medicine and Biomarker Development: One key trend in the immunology market is the increasing focus on personalized medicine. Researchers and pharmaceutical companies are investing in the development of biomarkers to identify patient subgroups most likely to respond to specific immunology therapies. This trend aims to improve treatment outcomes and reduce the risk of adverse effects.
  • Rising Interest in Gene Therapies: Gene therapies have gained momentum in the field of immunology. In 2022, there was growing interest in using gene editing techniques to modulate the immune system and target specific genetic factors contributing to autoimmune diseases. Although still in its early stages, gene therapy holds significant promise for the future of immunology treatment.

Immunology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global immunology market analysis, North America currently dominates the market, attributed to several factors, including a high prevalence of autoimmune diseases and immune-related disorders, a sedentary lifestyle, and significant technological advancements in immunology treatments. Additionally, the presence of key market players in the region further contributes to its market leadership. Conversely, the Asia Pacific region is experiencing the fastest growth rate in the global immunology market. This growth is fueled by increased screening for autoimmune diseases, economic growth leading to improved healthcare access, favorable reimbursement policies, and government initiatives aimed at enhancing healthcare infrastructure and services. The global immunology market encompasses a wide range of treatment options and therapies designed to modulate the immune system. Monoclonal antibodies, in particular, dominate the market segment due to their efficacy in specifically targeting components of the immune system and providing tailored therapy for autoimmune diseases. Biomaterials play a significant role in the market, with biologics, including monoclonal antibodies and other protein-based therapeutics, holding a major share. These biologics are favored for their high specificity and reduced side effects compared to traditional small-molecule drugs, driving the growth of the market. The global immunology market is primarily driven by factors such as the increasing prevalence of autoimmune diseases and allergies, the growing aging population, advancements in biotechnology and genomics, and a rising demand for personalized and targeted therapies. Additionally, the market is benefiting from the growing adoption of immunotherapies in various oncology treatments, further expanding its scope. The market also faces challenges, including high treatment costs, stringent regulatory processes for approval, potential side effects and complications associated with immunomodulatory therapies, and the availability of alternative treatment options. Personalized Medicine and Biomarker Development is a growing focus on personalized medicine in the field of immunology.

Researchers and pharmaceutical companies are investing in the development of biomarkers to identify patient subgroups most likely to respond to specific immunology therapies, leading to improved treatment outcomes and reduced adverse effects. Gene therapies have gained momentum in the immunology market. In recent years, there has been increasing interest in using gene editing techniques to modulate the immune system and target specific genetic factors contributing to autoimmune diseases and immune-related disorders. Gene therapies offer the potential for long-lasting and curative treatments in certain conditions. The global immunology market presents opportunities for market players to innovate, expand their product offerings, and cater to the evolving needs of healthcare providers and patients worldwide. The market's growth is expected to continue in the coming years, driven by ongoing research and development efforts in immunology and biotechnology.

Report Metric Details
Market size value in 2023 USD 97.93 Billion
Market size value in 2031 USD 204.07 Billion
Growth Rate 8.5%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Drug Class
    • Monoclonal Antibody, Immunosuppressants, Fusion Proteins, and Others
  • Disease Indication
    • Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Johnson & Johnson (US)
  • Roche Holdings AG (Switzerland)
  • AbbVie Inc. (US)
  • Pfizer Inc. (US)
  • Novartis International AG (Switzerland)
  • Merck & Co., Inc. (US)
  • Bristol-Myers Squibb Company (US)
  • Amgen Inc. (US)
  • Eli Lilly and Company (US)
  • AstraZeneca PLC (UK)
  • Gilead Sciences, Inc. (US)
  • Sanofi (France)
  • Biogen Inc. (US)
  • Regeneron Pharmaceuticals, Inc. (US)
  • Celgene Corporation (US)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Boehringer Ingelheim International GmbH (Germany)
  • Janssen Pharmaceuticals (US)
  • UCB S.A. (Belgium)
  • Genentech, Inc. (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Immunology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Immunology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Immunology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Immunology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Immunology Market size was valued at USD 97.93 Billion in 2021 and is poised to grow from USD 106.25 Billion in 2022 to USD 204.07 Billion by 2030, at a CAGR of 8.5% during the forecast period (2023-2030).

The immunology market is characterized by intense competition among key players striving to gain a significant market share. The market is witnessing the participation of both established pharmaceutical companies and emerging biotechnology firms, all vying to develop innovative immunological therapies and gain a competitive edge. companies in the immunology market focus on securing regulatory approvals for their products, adhering to stringent quality and safety standards. They also emphasize post-market surveillance and pharmacovigilance to ensure the continued efficacy and safety of their therapies. 'Johnson & Johnson (US)', 'Roche Holdings AG (Switzerland)', 'AbbVie Inc. (US)', 'Pfizer Inc. (US)', 'Novartis International AG (Switzerland)', 'Merck & Co., Inc. (US)', 'Bristol-Myers Squibb Company (US)', 'Amgen Inc. (US)', 'Eli Lilly and Company (US)', 'AstraZeneca PLC (UK)', 'Gilead Sciences, Inc. (US)', 'Sanofi (France)', 'Biogen Inc. (US)', 'Regeneron Pharmaceuticals, Inc. (US)', 'Celgene Corporation (US)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Boehringer Ingelheim International GmbH (Germany)', 'Janssen Pharmaceuticals (US)', 'UCB S.A. (Belgium)', 'Genentech, Inc. (US)'

The rapid advancements in biotechnology have significantly contributed to the growth of the immunology market. The development of novel biologics and targeted therapies has revolutionized the treatment landscape for immune-related disorders. For example, in 2022, the FDA approved a new biologic called bimekizumab for the treatment of psoriasis and psoriatic arthritis. Bimekizumab demonstrated superior efficacy compared to existing treatments, highlighting the potential of biotechnology in driving innovation and improving patient outcomes.

Personalized Medicine and Biomarker Development: One key trend in the immunology market is the increasing focus on personalized medicine. Researchers and pharmaceutical companies are investing in the development of biomarkers to identify patient subgroups most likely to respond to specific immunology therapies. This trend aims to improve treatment outcomes and reduce the risk of adverse effects.

North America holds a significant share in the immunology market and dominates due to several factors. The region has a well-established healthcare infrastructure, a high prevalence of immune-related diseases, and a robust research and development sector. Additionally, North America boasts a strong presence of key market players and pharmaceutical companies focusing on immunological research and product development. The region's dominance is further supported by the favorable reimbursement policies and regulatory frameworks that facilitate the adoption of immunological therapies. With a strong emphasis on innovation and advanced healthcare services, North America continues to lead the immunology market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Immunology Market

Product ID: SQMIG35H2245

$5,300
BUY NOW GET FREE SAMPLE